Welcome to the DZIF -

the German Center for Infection Research

Research Areas

DZIF is doing research in nine areas:

News

News and Press Releases:

A scientist is working in a laboratory. She is wearing glasses, a white lab coat and blue gloves, and is holding a pipette as she works with samples. In the background are laboratory equipment and shelves of scientific supplies.
© TWINCORE/Grabowski

Preventing severe courses: new antibodies against hepatitis E

Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with weakened immune systems or pre-existing liver damage, and in pregnant women, the
Schematic representation of organs and tissues arranged in a circle and connected to all others by a network of arrows.
© Maria Rohm/Helmholtz Munich/DZD

The language of organs: how faulty communication leads to disease

Changes in diet and the environment constantly pose new challenges to the human metabolism. Different organs and tissues work together in complex interactions to keep the metabolism in balance. The
The picture shows the award ceremony at the Joint Annual Meeting of the DZIF and DGI. Three men are standing together, the middle one is holding a certificate with the title “DZIF Prize for Translational Infection Research 2024”. They are all smiling and wearing formal attire. The DZIF logo can be seen on a roll-up in the background.
© Matthias Balk

Prof. Peter G. Kremsner receives the DZIF Prize for Translational Infection Research 2024

Prof. Dr. Peter G. Kremsner, a renowned tropical medicine specialist and infection researcher, has been awarded the DZIF Prize for Translational Infection Research 2024. The award recognizes his
Four single images of differently stained tissue sections with  enclosed tuberculosis granuloma showing different structural elements and accumulated BTZ-043.
© CC BY 4.0/Images modified from: Römpp, A., Treu, A., Kokesch-Himmelreich, J. et al. The clinical-stage drug BTZ-043 accumulates in murine tuberculosis lesions and efficiently acts against Mycobacterium tuberculosis. Nat Commun 16, 826 (2025). https://doi.org/10.1038/s41467-025-56146-9.

Novel antibiotic BTZ-043 also reaches tuberculosis bacteria hiding in dead lung tissue

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment

What is the DZIF? Find out more in our

DZIF movie

More than 700 people work at the DZIF with the common goal of translating basic research into clinical practice. The well-being of the patient is our primary focus. Get more insight into the DZIF in our new DZIF film:

Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists
CAPTCHA
1 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Research in Focus

Our Partner Sites

Research areas
Contact person
Research areas
Contact person

Dr. Silke Hartmann

Hannover Medical School
Partner Site Manager Hannover - Braunschweig
Project Manager Community-Acquired Infections at Mucosal Interfaces
Location

Bonn - Köln

Research areas
Contact person

Prof. Dr. Oliver Cornely

University Hospital Cologne
Coordinator Product Development
Coordinator Clinical Trial Office (CTO)
Partner Site Speaker Bonn-Cologne

Prof. Dr. Achim Hörauf

University Hospital Bonn
Deputy Partner Site Speaker Bonn-Köln
Deputy Coordinator Malaria and Neglected Tropical Diseases
Location

Heidelberg

Research areas
Contact person

Prof. Dr. Stephan Urban

Heidelberg University
Deputy Coordinator Hepatitis
DZIF Professor "Translational Virology"
Partner Site Speaker Heidelberg
15
Databases- & Biobanks 2023